Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists

Huijuan Jin, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Candong Hong, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Shengcai Chen, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Yifan Zhou, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Yong Wang, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Ling Mao, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Yanan Li, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Quanwei He, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Man Li, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Ying Su, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
David Wang, Neurovascular Division, Department of Neurology, Barrow Neurological Institute/Saint Joseph Hospital Medical Center, Phoenix, AZ, USA.Follow
Longde Wang, Stroke Prevention and Control Steering Committee, National Health Commission of the People's Republic of China, Beijing, China hubo@mail.hust.edu.cn wangld@nhfpc.gov.cn.
Bo Hu, Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China hubo@mail.hust.edu.cn wangld@nhfpc.gov.cn.

Document Type

Article

Abstract

Coronavirus disease 2019 (COVID-19) has become a pandemic disease globally. Although COVID-19 directly invades lungs, it also involves the nervous system. Therefore, patients with nervous system involvement as the presenting symptoms in the early stage of infection may easily be misdiagnosed and their treatment delayed. They become silent contagious sources or 'virus spreaders'. In order to help neurologists to better understand the occurrence, development and prognosis, we have developed this consensus of prevention and management of COVID-19. It can also assist other healthcare providers to be familiar with and recognise COVID-19 in their evaluation of patients in the clinic and hospital environment.

Medical Subject Headings

Betacoronavirus (pathogenicity); COVID-19; COVID-19 Testing; Central Nervous System (physiopathology, virology); Central Nervous System Infections (diagnosis, physiopathology, therapy, virology); Clinical Laboratory Techniques (standards); Consensus; Coronavirus Infections (diagnosis, physiopathology, therapy, virology); Early Diagnosis; Host-Pathogen Interactions; Humans; Neurologists (standards); Pandemics; Pneumonia, Viral (diagnosis, physiopathology, therapy, virology); Predictive Value of Tests; Prognosis; SARS-CoV-2

Publication Date

6-1-2020

Publication Title

Stroke and vascular neurology

E-ISSN

2059-8696

Volume

5

Issue

2

First Page

146

Last Page

151

PubMed ID

32385132

Digital Object Identifier (DOI)

10.1136/svn-2020-000382

Link to Full Text

Share

COinS